LFST · ISSUER CIK 1845257
LifeStance Health Group, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 7 LifeStance Health Group, Inc. insiders reported $0.00 of open-market purchases and $378.8M of sales on SEC Form 4.
↗7 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 2 of 8 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$378.8MInsider selling
−$378.8MNet open-market
Sep 24, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 202616:24 | Sep 22, 2026 | LFST | Chief Executive Officer, Director | G · Gift | — | −300,000 | 948,247 | -24% | — | ||
| Sep 24, 202616:24 | Sep 22, 2026 | LFST | Chief Executive Officer, Director | G · Gift | — | +300,000 | 150,000 | — | — | ||
| Sep 15, 202616:16 | Sep 11, 2026 | LFST | 10% Owner · +2 joint | S · Sell | $12.29 | −18,409,705 | 79,691,702 | -19% | −$226.3M | ||
| Sep 4, 202616:52 | Sep 2, 2026 | LFST | Chief Executive Officer, Director | J · Other | — | −150,000 | 1,248,247 | -11% | — | ||
| Sep 4, 202616:51 | Sep 2, 2026 | LFST | Chief Technology Officer | S · Sell | $12.87 | −42,067 | 205,379 | -17% | −$541K | ||
| Aug 26, 202617:17 | Aug 24, 2026 | LFST | Chief People Officer | F · Tax | $12.16 | −8,156 | 413,881 | -2% | $99K | ||
| Aug 18, 202617:13 | Aug 14, 2026 | LFST | Director | S · Sell | $12.68 | −7,500 | 97,093 | -7% | −$95K | ||
| Aug 14, 202617:48 | Aug 13, 2026 | LFST | Director | S · Sell | $12.23 | −20,441 | 104,593 | -16% | −$250K | ||
| Aug 13, 202617:02 | Aug 11, 2026 | LFST | Director | S · Sell | $11.51 | −500,000 | 2,970,810 | -14% | −$5.8M | ||
| Aug 12, 202617:07 | Aug 10, 2026 | LFST | Chief Technology Officer | S · Sell10b5-1 | $10.85 | −44,394 | 247,446 | -15% | −$482K | ||
| Aug 12, 202617:02 | Aug 10, 2026 | LFST | 10% Owner · +2 joint | S · Sell | $10.62 | −13,643,207 | 98,101,407 | -12% | −$144.9M | ||
| Aug 12, 202616:59 | Aug 10, 2026 | LFST | Chief Operating Officer | S · Sell10b5-1 | $10.85 | −47,912 | 281,289 | -15% | −$520K |